Abstract
Overactive bladder (OAB) is a clinical syndrome that fortunately or unfortunately is defined by the classic trilogy of lower urinary tract symptoms. Naturally, these include urinary urgency, with or without urge incontinence, urinary frequency (voiding eight or more times in a 24-h period), and nocturia (waking up during periods of deep sleep to void at night). Overactive bladder as a symptom complex has the potential to inflict destructive effects on almost all aspects of ordinary life. The impingement on socialization is often intense. Patients suffering with overactive bladder tend to significantly restrict their daily activities which can lead to isolation with associated varying degrees of depression. Furthermore, when nocturia is the primary component, it can lead to serious sleep disturbance and diminished quality of life. Other deleterious effects of overactive bladder include impaired domestic and sexual function, as well as impaired work-related productivity. At this point, one must acknowledge that all of these aspects of OAB have even more considerable consequences when we are dealing with an elderly population; especially, when significant medical comorbidities are associated. For instance, an elderly woman with urinary urge incontinence (UUI) becomes a much higher risk for falls leading to debilitating fractures when compared to women without UUI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Staskin DR, Wein AJ, editors. New perspectives on the overactive bladder. Urology. 2002;60 Suppl:1–104.
DuBeau CE, Kiely DK, Resnick NM. Quality of life impact of urge incontinence in older persons: a new measure and conceptual structure. J Am Geriatr Soc. 1999;47:989–94.
Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6(11 suppl):S580–90.
Brown JS, Vittinghoff E, Wymann JE, et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000;48:721–5.
Gibbs RS. Danforth’s obstetrics and gynecology, 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 890–1. ISBN 9780781769372.
Ghosh AK. Mayo Clinic internal medicine concise textbook. Rochester: Mayo Clinic Scientific Press; 2008. p. 339. ISBN 9781420067514.
Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36. doi:10.1007/s00345-002-0301-4.
Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 1999;44:56–66.
Ouslander JG, Kane RL, Abrass IB. Urinary incontinence in elderly nursing home patients. JAMA. 1982;248:1194–8.
Coyne KS, Wein AJ, Tubaro A, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009;103 Suppl 3:4.
Dubeau CE, Simon SE, Morris JN. The effect of urinary incontinence on quality of life in older nursing home residents. J Am Geriatr Soc. 2006;54:1325.
MacDiarmid SA, Gwynn E. Physical disability, an emerging complication of urinary incontinence. In: Society for urodynamics and female urology annual meeting, Bahamas, 22–25 Feb 2006.
Brown JS, McGhan WF, Chokroverty S. Comorbidities associated with overactive bladder. Am J Manag Care. 2000;6:S574–9.
Wein AJ, Rovner ES. The overactive bladder: an overview of primary care health providers. Int J Fertil. 1999;44:56–66.
Abrams P. Overactive bladder syndrome and urinary incontinence. Oxford: Oxford University Press; 2011. p. 7–8. ISBN 9780199599394.
Wagner TH, Hu T-W. Economic costs of urinary incontinence in 1995. Urology. 1998;51:355–61.
Fantl J, Newman D, Colling J, et al. Clinical practice guideline number 2: urinary incontinence in adults: acute and chronic management. Rockville: US Department of Health and Human Services, Agency for Health Care Policy and Research; 1996 (AHCPR publication 96–0682). update.
Chapple RC, MacDairmid SA. Urodynamics made easy. New York: Churchill Livingston; 2000.
Andersson K-E. Potential benefits of muscarinic M3 receptor selectivity. Eur Urol Suppl. 2002;1:23–8.
Aboseif S, Tamaddon K, Chalfin S, Freedman S, Mourad MS, Chang JH, Kaptein JS. Sacral neuromodulation in functional urinary retention: an effective way to restore voiding. BJU Int. 2002;90:662–5.
Amundsen CL, Romero AA, Jamison MG, Webster GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology. 2005;66:746–50.
Andrews BJ, Reynard JM. Transcutaneous posterior tibial nerve stimulation for treatment of detrusor hyperreflexia in spinal cord injury. J Urol. 2003;170:926.
Bosch JL, Groen J. Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: long-term results of a prospective longitudinal study. J Urol. 2000;163:1219–22.
Brindley GS. Electrical stimulation in vesicourethral dysfunction: general principles; practical devices. In: Mundy AR, Stephenson TP, Wein AJ, editors. Urodynamics: principles, practices, application. London: Churchill Livingstone; 1994. p. 481–8.
Brindley GS. The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia. 1994;32:795–805.
Caldwell KP. The electrical control of sphincter incompetence. Lancet. 1963;2:174–5.
Chai TC, Mamo GJ. Modified techniques of S3 foramen localization and lead implantation in S3 neuromodulation. Urology. 2001;58:786–90.
Cohen BL, Tunuguntla HS, Gousse A. Predictors of success for first stage neuromodulation: motor versus sensory response. J Urol. 2006;175:2178–80. discussion 2180–1.
Congregado Ruiz B, Pena Outeirino XM, Campoy Martinez P, Leon Duenas E, Leal Lopez A. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol. 2004;45:65–9.
Cooperberg MR, Stoller ML. Percutaneous neuromodulation. Urol Clin North Am. 2005;32:71–8. vii.
Craggs M, McFarlane J. Neuromodulation of the lower urinary tract. Exp Physiol. 1999;84:149–60.
Dahms SE, Hohenfellner M, Thuroff JW. Sacral neurostimulation and neuromodulation in urological practice. Curr Opin Urol. 2000;10:329–35.
De Groat WC, Saum WR. Synaptic transmission in para-sympathetic ganglia in the urinary bladder of the cat. J Physiol. 1976;256:137–58.
De Groat WC, Nadelhaft I, Milne RJ, Booth AM, Morgan C, Thor K. Organization of the sacral parasympathetic reflex pathways to the urinary bladder and large intestine. J Auton Nerv Syst. 1981;3:135–60.
Dees JE. Contraction of the urinary bladder produced by electric stimulation. Preliminary report. Invest Urol. 1965;2:539–47.
Fischer J, Madersbacher H, Zechberger J, Russegger L, Huber A. Sacral anterior root stimulation to promote micturition in transverse spinal cord lesions. Zentralbl Neurochir. 1993;54:77–9.
Fowler CJ. Neurological disorders of micturition and their treatment. Brain. 1999;122(Pt 7):1213–31.
Goh M, Diokno AC. Sacral neuromodulation for nonobstructive urinary retention—is success predictable? J Urol. 2007;178:197–9. discussion 199.
Govier FE, Litwiller S, Nitti V, Kreder Jr KJ, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165:1193–8.
Griffiths D. Clinical studies of cerebral and urinary tract function in elderly people with urinary incontinence. Behav Brain Res. 1998;92:151–5.
Hassouna MM, Siegel SW, Nyeholt AA, Elhilali MM, van Kerrebroeck PE, Das AK, et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol. 2000;163:1849–54.
Hedlund H, Schultz A, Talseth T, Tonseth K, van der Hagen A. Sacral neuromodulation in Norway: clinical experience of the first three years. Scand J Urol Nephrol. 2002;36 Suppl 210:87–95.
Hijaz A, Vasavada SP, Daneshgari F, Frinjari H, Goldman H, Rackley R. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology. 2006;68:533–7.
Hohenfellner M, Schultz-Lampel D, Dahms S, Matzel K, Thuroff JW. Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction. J Urol. 1998;160:821–4.
Hohenfellner M, Thuroff JW, Schultz-Lampel D. Sacral root stimulation to treat micturation disorders [sakrale neuromodulation zur therapie von Miktionsstorungen]. Aktuelle Urol. 1992;23:1–10.
Janknegt RA, Hassouna MM, Siegel SW, Schmidt RA, Gajewski JB, Rivas DA, et al. Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol. 2001;39:101–6.
Jonas U, Tanagho EA. Studies on the feasibility of urinary bladder evacuation by direct spinal cord stimulation. II. Poststimulus voiding: a way to overcome outflow resistance. Invest Urol. 1975;13:151–3.
Jonas U, Fowler CJ, Chancellor MB, Elhilali MM, Fall M, Gajewski JB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001;165:15–9.
Klingler HC, Pycha A, Schmidbauer J, Marberger M. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology. 2000;56:766–71.
Koldewijn EL, Rijkhoff NJ, van Kerrebroeck EV, Debruyne FM, Wijkstra H. Selective sacral root stimulation for bladder control: acute experiments in an animal model. J Urol. 1994;151:1674–9.
Koldewijn EL, Rosier PF, Meuleman EJ, Koster AM, Debruyne FM, van Kerrebroeck PE. Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J Urol. 1994;152:2071–5.
Kruse MN, de Groat WC. Spinal pathways mediate coordinated bladder/urethral sphincter activity during reflex micturition in decerebrate and spinalized neonatal rats. Neurosci Lett. 1993;152:141–4.
Lee YH, Creasey GH. Self-controlled dorsal penile nerve stimulation to inhibit bladder hyperreflexia in incomplete spinal cord injury: a case report. Arch Phys Med Rehabil. 2002;83:273–7.
Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32:11–8.
Madersbacher H. Conservative therapy of neurogenic disorders of micturition. Urologe A. 1999;38:24–9.
Madersbacher H, Fischer J. Sacral anterior root stimulation: prerequisites and indications. Neurourol Urodyn. 1993;12:489–94.
Maher MG, Mourtzinos A, Zabihi N, Laiwalla UZ, Raz S, Rodriguez LV. Bilateral caudal epidural neuromodulation for refractory urinary retention: a salvage procedure. J Urol. 2007;177:2237–40. discussion 2241.
Malaguti S, Spinelli M, Giardiello G, Lazzeri M, van den Hombergh U. Neurophysiological evidence may predict the outcome of sacral neuromodulation. J Urol. 2003;170:2323–6.
Martin ET. Can cardiac pacemakers and magnetic resonance imaging systems co-exist? Eur Heart J. 2005;26(2005):325–7.
McGuire EJ, Zhang SC, Horwinski ER, Lytton B. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol. 1983;129:78–9.
Minardi D, Muzzonigro G. Lower urinary tract and bowel disorders and multiple sclerosis: role of sacral neuromodulation: a preliminary report. Neuromodulation. 2005;8:176–81.
Nashold Jr BS, Friedman H, Boyarsky S. Electrical activation of micturition by spinal cord stimulation. J Surg Res. 1971;11:144–7.
Nashold Jr BS, Friedman H, Glenn JF, Grimes JH, Barry WF, Avery R. Electromicturition in paraplegia. Implantation of a spinal neuroprosthesis. Arch Surg. 1972;104:195–202.
Pettit PD, Thompson JR, Chen AH. Sacral neuromodulation: new applications in the treatment of female pelvic floor dysfunction. Curr Opin Obstet Gynecol. 2002;14:521–5.
Rijkhoff NJ, Wijkstra H, van Kerrebroeck PE, Debruyne FM. Selective detrusor activation by electrical sacral nerve root stimulation in spinal cord injury. J Urol. 1997;157:1504–8.
Roguin A, Zviman MM, Meininger GR, Rodrigues ER, Dickfeld TM, Bluemke DA, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation. 2004;110:475–82.
Ruud Bosch JL, Groen J. Treatment of refractory urge urinary incontinence with sacral spinal nerve stimulation in multiple sclerosis patients. Lancet. 1996;348:717–9.
Scheepens WA, de Bie RA, Weil EH, van Kerrebroeck PE. Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol. 2002;168:2046–50.
Scheepens WA, van Koeveringe GA, de Bie RA, Weil EH, van Kerrebroeck PE. Urodynamic results of sacral neuromodulation correlate with subjective improvement in patients with an overactive bladder. Eur Urol. 2003;43:282–7.
Schmidt RA, Jonas U, Oleson KA, Janknegt RA, Hassouna MM, Siegel SW, van Kerrebroeck PE. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol. 1999;162:352–7.
Schultz-Lampel D, Jiang C, Lindstrom S, Thuroff JW. Experimental results on mechanisms of action of electrical neuromodulation in chronic urinary retention. World J Urol. 1998;16:301–4.
Schultz-Lampel D, Jiang C, Lindstrom S, Thuroff JW. Summation effect of bilateral sacral root stimulation. Eur Urol. 1998;33:61.
Shaker HS, Hassouna M. Sacral nerve root neuromodulation: an effective treatment for refractory urge incontinence. J Urol. 1998;159:1516–9.
Siegel SW. Selecting patients for sacral nerve stimulation. Urol Clin North Am. 2005;32:19–26.
Siegel SW, Catanzaro F, Dijkema HE, Elhilali MM, Fowler CJ, Gajewski JB, et al. Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology. 2000;56:87–91.
South MM, Romero AA, Jamison MG, Webster GD, Amundsen CL. Detrusor overactivity does not predict outcome of sacral neuromodulation test stimulation. Int Urogynecol J. 2007;18(12):1395–8.
Spinelli M, Bertapelle P, Cappellano F, Zanollo A, Carone R, Catanzaro F, et al. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J Urol. 2001;166:541–5.
Spinelli M, Giardiello G, Gerber M, Arduini A, van den Hombergh U, Malaguti S. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol. 2003;170:1905–7.
Swinn MJ, Kitchen ND, Goodwin RJ, Fowler CJ. Sacral neuromodulation for women with Fowler’s syndrome. Eur Urol. 2000;38:439–43.
Van Balken MR, Vandoninck V, Gisolf KW, Vergunst H, Kiemeney LA, Debruyne FM, Bemelmans BL. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol. 2001;166:914–8.
Van Balken MR, Vandoninck V, Messelink BJ, Vergunst H, Heesakkers JP, Debruyne FM, et al. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur Urol. 2003;43:158–63. discussion 163.
Van Kerrebroeck EV, Scheepens WA, de Bie RA, Weil EH. European experience with bilateral sacral neuromodulation in patients with chronic lower urinary tract dysfunction. Urol Clin North Am. 2005;32:51–7.
Van Kerrebroeck EV, van der Aa HE, Bosch JL, Koldewijn EL, Vorsteveld JH, Debruyne FM. Sacral rhizotomies and electrical bladder stimulation in spinal cord injury. Part I: clinical and urodynamic analysis. Dutch Study Group on Sacral Anterior Root Stimulation. Eur Urol. 1997;31:263–71.
Vandoninck V, van Balken MR, Finazzi Agro E, Petta F, Micali F, Heesakkers JP, Debruyne FM, Kiemeney LA, Bemelmans BL. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn. 2003;22:227–32.
Wang Y, Hassouna MM. Electrical stimulation has no adverse effect on pregnant rats and fetuses. J Urol. 1999;162:1785–7.
Wein A, Barrett D. Voiding function and dysfunction—a logical and practical approach. Year Book Medical. Chicago; 1988.
Wheeler Jr JS, Walter JS, Sibley P. Management of incontinent SCI patients with penile stimulation: preliminary results. J Am Paraplegia Soc. 1994;17:55–9.
Wheeler Jr JS, Walter JS, Zaszczurynski PJ. Bladder inhibition by penile nerve stimulation in spinal cord injury patients. J Urol. 1992;147:100–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this chapter
Cite this chapter
Singh, R., Rackley, R., Vasavada, S., Gordon, D.A. (2017). Overactive Bladder (OAB) in the Elderly with Contemporary Notions on Treatment Including Sacral Nerve Stimulation (SNS). In: Gordon, D., Katlic, M. (eds) Pelvic Floor Dysfunction and Pelvic Surgery in the Elderly. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-6554-0_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6554-0_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-6552-6
Online ISBN: 978-1-4939-6554-0
eBook Packages: MedicineMedicine (R0)